Skip to main content

D. E. Shaw & Co., Inc.

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 1009207 New York, NY

Position in ACRS

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$3,378,015
-$2,932,904 QoQ
Shares Held
900,804
-57.0% QoQ
Ownership
0.645%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Jun 2021
15 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in ACRS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. ACRS ranks #102 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in ACRS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $3,378,015 900,804
2025-12-31 $6,310,919 2,096,651
2025-09-30 $4,509,129 2,373,226
2025-06-30 $3,976,400 2,800,282
2025-03-31 $4,505,103 2,944,512
2024-12-31 $8,168,189 3,293,625
2024-09-30 $3,877,625 3,371,849
2024-06-30 $3,652,226 3,320,206
2024-03-31 $4,070,896 3,282,982
2023-12-31 $2,035,959 1,939,010
2023-09-30 $452,168 66,010
2023-06-30 $299,931 28,923
2021-12-31 $332,442 22,864
2021-09-30 $1,145,196 63,622
2021-06-30 $4,728,117 269,255